Clinical trial
Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma
NCT03825302 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- December 1, 2021
- Completion date
- December 1, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.